Christopher G. Hayes, Chief Legal Officer at Verrica Pharmaceuticals Inc. (VRCA), bought 7,500 shares at $3.40 ($26K) on 2022-07-11, disclosed to the SEC on 2022-07-11.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Clearly above the average filing.
| Filing → |
| VRCA | SELL | 2024-07-23 | $306K | — | Filing → |
| VRCA | SELL | 2023-11-16 | $164K | — | Filing → |
| VRCA | SELL | 2023-07-25 | $326K | — | Filing → |